Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales
Fed Rate Hike Expectations Return as Traders Price in Move by December After Inflation Surge
Aluminum Price Surge Driven by Geopolitical Tensions Poses Cost Challenges for Major US Corporations
Arvind Sanger of Geosphere Capital Cautiously Optimistic on India as Earnings Revival Takes Center Stage
SEBI Chief Tuhin Kanta Pandey Highlights Indias Diversified Market Amid Taiwans Ascent on TSMC and AI Boom
Social Security Claiming Dilemma Early Benefits at 62 vs Survivors Option at 67 for LowerIncome Retirees
iBio Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 33
CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances
ADPT Q1 2026 Earnings EPS Surpasses Estimates as Company Shows Operational Progress
SVC Q1 2026 Earnings Massive EPS Miss Exposes Hotel Net Lease Headwinds
SCSC Q1 2026 Earnings Slight EPS Miss but Stock Gains on Solid Performance
NRG Q1 2026 Earnings EPS Misses Expectations Amid Mixed Performance
iShares Staked Ethereum Trust ETHB Edges Lower Amid Cautious Crypto Market Sentiment
Alerus Financial ALRS Sees Modest Decline Amidst Broader Financial Sector Pressures
Red Violet RDVT Surges 41 as Momentum Builds Toward Key Resistance Level
StoneBridge Acquisition II Units APACU Hold Near 1020 as SPAC Market Shows Measured Activity
Corporacion America Airports CAAP Gains 236 Support and Resistance Levels in Focus
Technical Assessment Points to Potential IntermediateTerm Bullish Outlook
Gold and Silver Decline as Precious Metals Retreat from Recent Highs
US Jobless Claims Slide to Lowest Since MidMay Underlining Labor Market Resilience
Shameful Imbalance Youth Benefit Spending Outpaces Job Investment Says Former Minister
HDFC Bank Shares Dip 2 as Internal Vigilance Probe Into 45 Crore MSRDC Interest Payments Emerges
401k Millionaire Count Dips as Workers Boost Savings to Record Levels Fidelity Q1 Data
AnheuserBusch InBev Shares Dip as Quarterly Sales Miss Analyst Expectations
TSCO Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Cost Pressures
Design Therapeutics DSGN Declines 2 as Shares Test Key Support Levels